skip navigation nih record
Vol. LXVII, No. 7
March 27, 2015
cover

previous story

next story


Briefs

Professor and Author Beilock Gives DDM Talk

The Deputy Director for Management announces the second DDM seminar of the 2014-2015 series “Management and Science: Partnering for Excellence.” The event on Thursday, Apr. 9 from 11 a.m. to 12:30 p.m. in Masur Auditorium, Bldg. 10, will feature Dr. Sian Beilock, who will discuss “How To Perform Your Best Under Stress.” She will focus on strategies, tips and tools for performing at our peak.

Videocasting and sign language will be provided. Individuals who need reasonable accommodation to attend should contact the NIH Training Center at (301) 496-6211 or the Federal Relay Service at 1-800-877-8339.

For more information about the series, visit www.ddmseries.od.nih.gov or call (301) 496-3271.

NCATS Seminar, Meetings on Pfizer Centers

NCATS will host a seminar on Monday, Apr. 13 from 2 to 5 p.m. at Lister Hill Auditorium, Bldg. 38A, as well as one-on-one meetings on Apr. 14 by appointment for NIH intramural researchers interested in Pfizer’s Centers for Therapeutic Innovation (CTI) collaborative opportunities.

The CTI model is the first NIH-wide biologics initiative with a pharmaceutical partner that NCATS will coordinate on behalf of all NIH intramural researchers; NIH investigators will be paired with Pfizer resources to pursue scientific and medical advances through joint therapeutic development.

The goal of this new collaboration is to identify biologic compounds with activity in a pathway or target of interest to an NIH intramural researcher and to Pfizer. Together, the partners will work to move these compounds into the clinic to test them. The first Pfizer call for proposals from NIH intramural researchers is slated for spring 2015. Other partners in the CTI network include 25 academic institutions and 4 patient foundations.

For more information and to register for the April dates, contact Lili Portilla, NCATS director of strategic alliances, at NIH-PfizerCTI@mail.nih.gov. For more information about the Pfizer CTI for NIH researchers, visit www.ncats.nih.gov/cti.html.

NIH Employee Intranet Debuts

NIH Employee Intranet Debuts

Is your list of Internet bookmarks as long as a, er, book? Here’s something to put at the top of the list—the NIH Employee Intranet.

Need links to ITAS, web email, the IT Service Desk, MyPay and the NED staff directory? Need to know the OPM operating status? Want easy access to the campus map, shuttle schedule, payroll calendar or the NIH Record? With the NIH Employee Intranet, it’s all here, plus a lot more.

Be sure to bookmark the NIH Employee Intranet at http://employees.nih.gov for frequently used links, announcements and resources that matter to you as an NIH employee. If it looks a little familiar, that’s because we’ve transformed the former For Employees web page into the NIH Employee Intranet.

The NIH Employee Intranet is accessible only inside the NIH network, whether you’re physically at an NIH facility or teleworking remotely with a VPN account. If you need frequently used links when you’re not logged on, you may find this web page useful: www.nih.gov/employee/employeeresources.htm.

NIAMS, NIAID and FNIH Host AMP Investigators

NIAMS, NIAID and the Foundation for the National Institutes of Health recently held a 2-day meeting to bring together, for the first time, investigators participating in the Accelerating Medicines Partnership (AMP) Rheumatoid Arthritis (RA) and Lupus Network.
NIAMS, NIAID and the Foundation for the National Institutes of Health recently held a 2-day meeting to bring together, for the first time, investigators participating in the Accelerating Medicines Partnership (AMP) Rheumatoid Arthritis (RA) and Lupus Network. The network, which was funded last fall, is part of a larger public-private partnership between NIH, industry and health advocacy organizations to speed the development of new therapies for patients with lupus and RA. The researchers discussed the unique capabilities and research interests of each network site. With that background, they developed a 5-year vision for the network and set out immediate near-term goals. Network investigators presented their goals and plans to members of the network steering committee. The meeting helped researchers harmonize their individual efforts into a collaborative framework and generated excitement about the potential of this effort to transform rheumatic disease research.

NIAMS Discusses 3-D Human Tissue Models

As part of the NIAMS scientific planning process, NIH-funded investigators recently met with institute leadership and staff for a day-long discussion of Opportunities and Challenges in Developing 3-Dimensional Human Tissue Models to Study Musculoskeletal and Skin Physiology and Pathophysiology. NIAMS director Dr. Stephen Katz, deputy director Dr. Robert Carter, program directors Drs. Carl Baker and Fei Wang and Duke University professor Dr. Farshid Guilak led the forum. Program staff from four other ICs [Drs. Denis Buxton (NHLBI), Rosemarie Hunziker (NIBIB), Nadya Lumelsky (NIDCR) and Dan Tagle (NCATS)] also contributed to the discussion, which focused on existing models and ongoing efforts that could facilitate an understanding of disease pathogenesis, functional studies of gene variants, high-throughput drug screening, drug toxicity studies or testing of potential therapies. Researchers also described impediments to model development and proposed approaches to overcome these hurdles.
As part of the NIAMS scientific planning process, NIH-funded investigators recently met with institute leadership and staff for a day-long discussion of Opportunities and Challenges in Developing 3-Dimensional Human Tissue Models to Study Musculoskeletal and Skin Physiology and Pathophysiology. NIAMS director Dr. Stephen Katz, deputy director Dr. Robert Carter, program directors Drs. Carl Baker and Fei Wang and Duke University professor Dr. Farshid Guilak led the forum. Program staff from four other ICs [Drs. Denis Buxton (NHLBI), Rosemarie Hunziker (NIBIB), Nadya Lumelsky (NIDCR) and Dan Tagle (NCATS)] also contributed to the discussion, which focused on existing models and ongoing efforts that could facilitate an understanding of disease pathogenesis, functional studies of gene variants, high-throughput drug screening, drug toxicity studies or testing of potential therapies. Researchers also described impediments to model development and proposed approaches to overcome these hurdles.

Next Protocol Navigation Lecture, Apr. 6

The IRP Protocol Navigation Training Program Seminar Series continues with a lecture to be held Monday, Apr. 6 from 2 to 3 p.m. in Bldg. 50, Conf. Rm. 1227/1328. Dr. Jonathan M. Gitlin of NHGRI’s Division of Policy, Communications and Education will present “FDA and the Regulation of Genomic Diagnostics in Research and Medicine.” For more information, contact Marcia Vital, (301) 451-9437, vitalm@mail.nih.gov.


back to top of page